Novo Nordisk A S (NVO) EBT (2012 - 2016)
Novo Nordisk A S's (NVO) quarterly EBT came in at $1.9 billion in Q2 2016, up 22.67% YoY from $1.6 billion in Q3 2015, and up 8.22% on a QoQ basis from $1.8 billion in Q1 2016.
Novo Nordisk A S (NVO) EBT (2012 - 2016) Analysis & Trends
Novo Nordisk A S (NVO) has 5 years of EBT data on file, last reported at $1.9 billion in Q2 2016.
- Quarterly EBT rose 22.67% year-over-year to $1.9 billion in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $6.7 billion (up 5.65% YoY) and the FY2019 annual result came in at $178.1 billion, up 12.71% from the prior year.
- EBT improved to $1.9 billion in Q2 2016, from $1.8 billion in the prior quarter.
- In the past five years, EBT ranged from a high of $1.9 billion in Q2 2016 to a low of $1.1 billion in Q1 2012.
- A 5-year average of $1.5 billion and a median of $1.5 billion in 2014 frame the typical range for EBT.
- Annual changes were most pronounced in 2013 — EBT gained 28.75% — and 2016, when it dropped 6.42%.
- Tracing NVO's EBT over 5 years: stood at $1.3 billion in 2012, then advanced by 9.81% to $1.4 billion in 2013, then fell by 2.04% to $1.4 billion in 2014, then increased by 8.47% to $1.5 billion in 2015, then climbed by 26.41% to $1.9 billion in 2016.
- The last three EBT figures came in at $1.9 billion (Q2 2016), $1.8 billion (Q1 2016), and $1.5 billion (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.91 Bn |
| Mar 31, 2016 | 1.77 Bn |
| Dec 31, 2015 | 1.51 Bn |
| Sep 30, 2015 | 1.51 Bn |
| Jun 30, 2015 | 1.56 Bn |
| Mar 31, 2015 | 1.89 Bn |
| Dec 31, 2014 | 1.39 Bn |
| Sep 30, 2014 | 1.50 Bn |
| Jun 30, 2014 | 1.65 Bn |
| Mar 31, 2014 | 1.52 Bn |
| Dec 31, 2013 | 1.42 Bn |
| Sep 30, 2013 | 1.47 Bn |
| Jun 30, 2013 | 1.52 Bn |
| Mar 31, 2013 | 1.38 Bn |
| Dec 31, 2012 | 1.30 Bn |
| Sep 30, 2012 | 1.24 Bn |
| Jun 30, 2012 | 1.20 Bn |
| Mar 31, 2012 | 1.07 Bn |